- Home
- RGC vs USAS Comparison
RGC vs USAS Comparison
Compare RGC & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGC
- USAS
- Stock Information
- Founded
- RGC 2014
- USAS 1998
- Country
- RGC Hong Kong
- USAS Canada
- Employees
- RGC N/A
- USAS N/A
- Industry
- RGC Medicinal Chemicals and Botanical Products
- USAS Metal Mining
- Sector
- RGC Health Care
- USAS Basic Materials
- Exchange
- RGC Nasdaq
- USAS Nasdaq
- Market Cap
- RGC 377.5M
- USAS 386.9M
- IPO Year
- RGC 2021
- USAS N/A
- Fundamental
- Price
- RGC $366.01
- USAS $0.61
- Analyst Decision
- RGC
- USAS Strong Buy
- Analyst Count
- RGC 0
- USAS 1
- Target Price
- RGC N/A
- USAS $1.00
- AVG Volume (30 Days)
- RGC 128.0K
- USAS 1.5M
- Earning Date
- RGC 06-20-2025
- USAS 05-09-2025
- Dividend Yield
- RGC N/A
- USAS N/A
- EPS Growth
- RGC N/A
- USAS N/A
- EPS
- RGC N/A
- USAS N/A
- Revenue
- RGC N/A
- USAS $102,883,000.00
- Revenue This Year
- RGC N/A
- USAS $45.78
- Revenue Next Year
- RGC N/A
- USAS $17.98
- P/E Ratio
- RGC N/A
- USAS N/A
- Revenue Growth
- RGC N/A
- USAS 8.12
- 52 Week Low
- RGC $3.03
- USAS $0.21
- 52 Week High
- RGC $250.00
- USAS $0.65
- Technical
- Relative Strength Index (RSI)
- RGC 93.65
- USAS 55.04
- Support Level
- RGC $27.70
- USAS $0.59
- Resistance Level
- RGC $250.00
- USAS $0.64
- Average True Range (ATR)
- RGC 40.23
- USAS 0.05
- MACD
- RGC 29.16
- USAS -0.00
- Stochastic Oscillator
- RGC 96.17
- USAS 68.53
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.